Del-Immune V imitator loses in court
This article was originally published in The Tan Sheet
Executive Summary
The Russian Choice Immune probiotic supplement falsely advertised it was identical to Pure Research Products' Del-Immune V, a federal jury in Denver determines. The imitator's marketer, Kikkoman Corp., a subsidiary of Allergy Research Group, also misled consumers by claiming the Vietnamese product originated in Russia, PRP said March 9. Del-Immune V's proprietary strain was licensed from Russian scientists in 2002, but is made in the U.S., according to Boulder, Colo.-based PRP. An analytical comparison of Del-Immune V and Russian Choice Immune posted on PRP's Web site found "dramatically higher amounts of protein, DNA, nuclear proteins and microelements" in Del-mmune V
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.